Filing Details

Accession Number:
0001012975-17-000656
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-24 17:48:59
Reporting Period:
2017-08-22
Accepted Time:
2017-08-24 16:48:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326190 Altimmune Inc. ALT Pharmaceutical Preparations (2834) 202726770
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1428764 David Drutz C/O Altimmune, Inc.
19 Firstfield Road, Suite 200
Gaithersburg MD 20878
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Acquisiton 2017-08-22 5,000 $2.15 25,777 No 4 P Direct
Common Stock, Par Value $0.0001 Acquisiton 2017-08-23 5,000 $2.27 30,777 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $2.08 to $2.16 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.
  2. The price reflected is the weighted-average purchase price for shares purchased. The range of purchase prices for the transactions reported was $2.23 to $2.28 per share. The Reporting Person undertakes to provide, upon request by the Issuer, any security holder of the Issuer, or the SEC staff, full information regarding the number of shares purchased at each separate price.